[TRIAL TREATMENT OF HEPATIC METABOLIC DISORDERS BY AN ORIGINAL FORMULA CONTAINING MAINLY ORNITHINE COMBINED WITH VARIOUS CLASSICAL LIPOTROPIC SUBSTANCES].
D000470:Alkaloids; D001161:Arteriosclerosis; D002784:Cholesterol / Q000097:blood*; D002951:Citrates; D006801:Humans; D050356:Lipid Metabolism; D008082:Lipotropic Agents; D008107:Liver Diseases; D008274:Magnesium; D009952:Ornithine; D011736:Pyridoxine; D013012:Sorbitol
D000470:Alkaloids; D002951:Citrates; D008082:Lipotropic Agents; D013012:Sorbitol; D002784:Cholesterol; D009952:Ornithine; D008274:Magnesium; D011736:Pyridoxine
ALKALOIDS; ARTERIOSCLEROSIS; BLOOD CHOLESTEROL; CITRATES; LIPID METABOLISM; LIVER DISEASES; MAGNESIUM; ORNITHINE; PYRIDOXINE; SORBITOL
ESSAI DE TRAITEMENT DES DYSM'ETABOLIES H'EPATIQUES PAR UNE FORMULE ORIGINALE COMPORTANT POUR LA PREMI'ERE FOIS DE L'ORNITHINE ASSOCI'EE 'A DIVERSES SUBSTANCES LIPOTROPES CLASSIQUES.